The Bronchiectasis drugs in development market research report provides comprehensive information on the therapeutics under development for Bronchiectasis, complete with analysis by stage of ...

The cathepsin C (CatC) inhibitor BI 1291583 is associated with a decreased risk for an exacerbation in adults with bronchiectasis, according to study findings published in the European Respiratory ...

Insmed Inc. (INSM) said it presented positive late-breaking subgroup data from the Phase 3 ASPEN study, a global, randomized, ...

Electromed specializes in HFCWO therapy with its SmartVest System, targeting respiratory diseases. Find out my recommendation ...

Four-year-old Nathan Tasker, who lives with cerebral palsy, and other kids from across WA will be able to benefit from a $3.6 ...

Children were 50% more likely to be diagnosed with diabetes around six months after contracting the coronavirus infection ...

gmail.com Aim To determine whether a child with chronic wet cough and poor response to at least 4 weeks of oral antibiotics is more likely to have bronchiectasis. Methods All chest multi-detector ...

University of California San Diego and University of California Berkeley researchers have been awarded up to $7 million from ...

BRIDGEWATER, N.J. - Insmed (NASDAQ:INSM) Incorporated (NASDAQ:INSM), a global biopharmaceutical company, announced consistent positive results from its Phase 3 ASPEN study of brensocatib in treating ...

Insmed Inc (INSM) reports robust financial performance and outlines strategic initiatives for upcoming product launches amid ...